These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31055730)

  • 41. Correlation between matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 and white matter hyperintensities in patients with cerebral small vessel disease based on cranial magnetic resonance 3D imaging.
    Luo BL; He SP; Zhang YF; Yang QW; Zhuang JC; Zhu RJ; Zheng YQ; Su HM
    Magn Reson Imaging; 2024 Nov; 113():110213. PubMed ID: 39053592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two motor subtype classifications in de novo Parkinson's disease.
    Choi SM; Kim BC; Cho BH; Kang KW; Choi KH; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
    Parkinsonism Relat Disord; 2018 Sep; 54():74-78. PubMed ID: 29703644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease.
    Dadar M; Miyasaki J; Duchesne S; Camicioli R
    Parkinsonism Relat Disord; 2021 Apr; 85():95-101. PubMed ID: 33770671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
    Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load.
    Fang E; Ann CN; Maréchal B; Lim JX; Tan SYZ; Li H; Gan J; Tan EK; Chan LL
    J Magn Reson Imaging; 2020 Mar; 51(3):748-756. PubMed ID: 31365182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional homogeneity alterations differentiate between tremor dominant and postural instability gait difficulty subtypes of Parkinson's disease.
    Jiang S; Wang M; Zhang L; Yuan Y; Tong Q; Ding J; Wang J; Xu Q; Zhang K
    J Neural Transm (Vienna); 2016 Mar; 123(3):219-29. PubMed ID: 26666253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease.
    Chen H; Wan H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Feng T; Wang Y
    Parkinsonism Relat Disord; 2021 Feb; 83():86-92. PubMed ID: 33493785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.
    dos Santos EF; Busanello EN; Miglioranza A; Zanatta A; Barchak AG; Vargas CR; Saute J; Rosa C; Carrion MJ; Camargo D; Dalbem A; da Costa JC; de Sousa Miguel SR; de Mello Rieder CR; Wajner M
    Metab Brain Dis; 2009 Jun; 24(2):257-69. PubMed ID: 19294496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perturbation Treadmill Training Improves Clinical Characteristics of Gait and Balance in Parkinson's Disease.
    Gaßner H; Steib S; Klamroth S; Pasluosta CF; Adler W; Eskofier BM; Pfeifer K; Winkler J; Klucken J
    J Parkinsons Dis; 2019; 9(2):413-426. PubMed ID: 30958316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
    Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebellar alterations in Parkinson's disease with postural instability and gait disorders.
    Gardoni A; Agosta F; Sarasso E; Basaia S; Canu E; Leocadi M; Castelnovo V; Tettamanti A; Volontè MA; Filippi M
    J Neurol; 2023 Mar; 270(3):1735-1744. PubMed ID: 36534200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Neural Basis of Postural Instability Gait Disorder Subtype of Parkinson's Disease: A PET and fMRI Study.
    Zhang L; Li TN; Yuan YS; Jiang SM; Tong Q; Wang M; Wang JW; Chen HJ; Ding J; Xu QR; Zhang KZ
    CNS Neurosci Ther; 2016 May; 22(5):360-7. PubMed ID: 26842842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Falls in persons with Parkinson's disease: Do non-motor symptoms matter as much as motor symptoms?
    Alvarado-Bolaños A; Cervantes-Arriaga A; Arredondo-Blanco K; Salinas-Barboza K; Isais-Millán S; Rodríguez-Violante M
    Arq Neuropsiquiatr; 2019 Nov; 77(11):761-767. PubMed ID: 31826131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between homocysteine and white matter hyperintensities in rural-dwelling Chinese people with asymptomatic intracranial arterial stenosis: A population-based study.
    Wang X; Yin H; Ji X; Sang S; Shao S; Wang G; Lv M; Xue F; Du Y; Sun Q
    Brain Behav; 2021 Jul; 11(7):e02205. PubMed ID: 34032023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype.
    Ba F; Obaid M; Wieler M; Camicioli R; Martin WR
    Can J Neurol Sci; 2016 Mar; 43(2):261-7. PubMed ID: 26949837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. White matter hyperintensities associated with impulse control disorders in Parkinson's Disease.
    Hernadi G; Perlaki G; Kovacs M; Pinter D; Orsi G; Janszky J; Kovacs N
    Sci Rep; 2023 Jun; 13(1):10594. PubMed ID: 37391475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
    Zoccolella S; Lamberti P; Iliceto G; Diroma C; Armenise E; Defazio G; Lamberti SV; Fraddosio A; de Mari M; Livrea P
    Clin Chem Lab Med; 2005; 43(10):1107-10. PubMed ID: 16197306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study.
    Huang X; Ng SY; Chia NS; Acharyya S; Setiawan F; Lu ZH; Ng E; Tay KY; Au WL; Tan EK; Tan LC
    Parkinsonism Relat Disord; 2018 Oct; 55():50-54. PubMed ID: 29779681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.